The order from the Securities and Exchange Commission (SEC) asserted that over around ten years, Goldman made more than 22,000 deficient blue sheet submissions. Goldman Sachs has settled a $6 million ...
Inozyme Pharma, Inc. announced that Dr. Kurt Gunter, the company's Senior Vice President and Chief Medical Officer, will present data on the Expanded Access Program for their therapeutic candidate INZ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results